NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Drug Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Biomedical Engineering



Leading Biotechnology Organizations Praise Effort and Express Concerns with New Follow-on Biologics Proposal



July 10th, 2007

The Biologics Price Competition and Innovation Act of 2007 (BPCIA), reported out today by the Senate Health, Education, Labor and Pensions (HELP) Committee by voice vote, takes an important step toward establishing a pathway for approval of follow-on biologics, ensuring access for patients to life saving biologics, and protecting continued biomedical innovation, said the Biotechnology Industry Organization (BIO), the nation's largest biotechnology trade association, and the Massachusetts Biotechnology Council (MBC), one of the largest state biotechnology trade associations. The organizations stated, however, that the bill also includes several provisions that cause concern for...


Source: Drug Law Weekly (2007-07-10)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login